EtusivuHLN • LON
Haleon PLC
380,20 GBX
17.4., 17.30.00 UTC+1 · GBX · LON · Vastuuvapauslauseke
OsakeListattu pörssissä GB
Viimeisin päätös
382,80 GBX
Päivän väli
378,10 GBX - 381,50 GBX
Vuoden väli
319,84 GBX - 417,70 GBX
Markkina-arvo
45,97 mrd. USD
Keskim. volyymi
27,92 milj.
P/E-luku
24,19
Osinkotuotto
1,74 %
Ensisijainen pörssi
LON
Pörssiuutiset
UNH
22,38 %
.DJI
1,33 %
.INX
0,13 %
Tietoja
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 percent market share in 2022. Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Sir Dave Lewis is chairman, with Brian McNamara as CEO. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020. Wikipedia
Perustettu
18.7.2022
Sivusto
Henkilöstö
24 561
Haku
Tyhjennä haku
Sulje haku
Google-sovellukset
Päävalikko